Background | The Clinical Infectious Diseases Research Unit was established in 2000 in order to support and strengthen research activities especially vaccine and/or drug trials in the Department of Clinical Tropical Medicine, notably HIV, Dengue, HPV, Influenza vaccine, Chikungunya, COVID vaccine etc. |
Activities (TRO) | – Teaching (การเรียนการสอน) Master of Science in Tropical Medicine, M.Sc. (Trop. Med.) Doctor of Philosophy in Tropical Medicine, Ph. D. (Trop. Med.) Master of Clinical Tropical Medicine (M.C.T.M.) Doctor of Philosophy in Clinical Tropical Medicine, Ph.D. (Clin. Trop. Med.) Graduate Diploma in Tropical Medicine & Hygiene (D.T.M.&H.) M.D. : Collaborative Project to Produce Rural Doctors (CPPRD) – Research (งานวิจัย) โครงการระยะสั้น - A Phase I/II Randomized Double Blind Controlled Study to Evaluate the Safety and Immunogenicity of GPO Seasonal Quadrivalent Inactivated Spilt Virion Influenza Vaccine in Healthy Thais
- Immune responses of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike (NDV-HXP-S) with heterogenous booster after 12 months in adults (NRCT 9-1)
- Immune responses, boosting effects of adults previously received two doses of inactivated COVID-19 vaccines and third doses of any COVID-19 vaccine with additional mRNA COVID-19 vaccine boost after one year (Protocol No.: NRCT 9-2)
- A Phase 2, Randomized, Double-blind, Placebo-controlled, Double-dummy, Multicenter Trial Assessing the Efficacy and Safety of Two Dose Regimens of JNJ-64281802 for the Prevention of Dengue Infection (AeDen Study: 64281802DNG2004)
- Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety and Immunogenicity of Vaccination with ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years and Older with a History of Urinary Tract Infection in the Past 2 Year (E.mbrace study: VAC52416BAC3001)
โครงการต่อเนื่อง - Randomized, Double Blind Evaluation of Late Boost Strategies with IHV01 (FLSC in aluminum phosphate) and A244 with or without ALFQ for HIV-uninfected Participants in the HIV Vaccine Trial RV306 / WRAIR1920 (RV546)
- A Phase II/III Adaptive Seamless Design, Randomized, Controlled Trial to Evaluate Safety and Immunogenicity of 2 Dose-Regimen of BBV87 Chikungunya Vaccine in Healthy Subjects Aged 12 to 65 years in Panama, Colombia, and Thailand (IVI CHIK-001)
– Outstanding (บริการวิชาการ) จัดกิจกรรมสร้างบ้านนก และยิงเมล็ดพันธุ์ อำเภอบ้านคา จังหวัดราชบุรี จัดกิจกรรมพาผู้สูงวัยไหว้พระรอบเกาะรัตนโกสินทร์ |